Thanks to decades of extensive scientific research, we now have extremely reliable ways to prevent HIV transmission. Here’s a breakdown of the tools you can use to prevent HIV.
Ending the HIV Epidemic Is a Team Effort. The New York City and State Health Departments Discuss Their Combined Work
Johanne Morne, M.S., and Oni Blackstock, M.D., sat down with TheBody to discuss their successes and their work to close the disparities gap.
What Needs to Happen Before California Pharmacies Can Sell PrEP and PEP Without an Initial Prescription
Pharmacists will increasingly play a role in pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP) access in California.
Plans to expand the program to the entire state are underway.
July 11, 2019: Seroconversion while on long-acting contraceptives; cardiovascular risk in people with HIV; suboptimal testing in high-prevalence U.S. areas; E/C/F/TAF may be suitable for PEP.
New York City aims to expand PrEP and PEP access by educating more clinicians that serve women.
A dial-in hotline program in New York City has helped qualified patients access post-exposure prophylaxis (PEP) at their local pharmacies, raising the possibility that remote screening methods could be an important way to bolster PEP use.
"I truly believe that HIV care remains an extraordinarily gratifying aspect of ID clinical practice," Paul Sax, M.D., writes. "Which is why it’s critical that ID doctors continue to do it."
Researchers examining issues facing post-exposure prophylaxis (PEP) users found that 74% of study participants had at least one psychosocial issue, including depression and/or problematic drug or alcohol use.
After the departure from clinical practice of three colleagues, Paul Sax, M.D., reflects on the state of U.S. health care and its frustrating "medicine-as-a-business" model.